|
DET1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.35390000322033E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20410001150873E-09 |
| Normal-vs-Stage2 |
2.723200E-03 |
| Normal-vs-Stage3 |
3.63380000000246E-05 |
| Normal-vs-Stage4 |
6.47440000000055E-05 |
| Stage1-vs-Stage2 |
6.251000E-01 |
| Stage1-vs-Stage3 |
7.799200E-01 |
| Stage1-vs-Stage4 |
8.359200E-01 |
| Stage2-vs-Stage3 |
5.371400E-01 |
| Stage2-vs-Stage4 |
5.884800E-01 |
| Stage3-vs-Stage4 |
9.820400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.40169999630314E-08 |
| Normal-vs-AfricanAmerican |
7.2771999981569E-08 |
| Normal-vs-Asian |
2.167200E-04 |
| Caucasian-vs-AfricanAmerican |
1.883950E-01 |
| Caucasian-vs-Asian |
4.330600E-01 |
| AfricanAmerican-vs-Asian |
6.845800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.58439997075288E-09 |
| Normal-vs-Female |
2.4087000000006E-05 |
| Male-vs-Female |
1.803600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.19109999999901E-05 |
| Normal-vs-Extreme_Weight |
2.99420000016148E-07 |
| Normal-vs-Obese |
4.19379999949676E-07 |
| Normal-vs-Extreme_Obese |
5.634500E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.571200E-01 |
| Normal_Weight-vs-Obese |
6.892400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.422000E-01 |
| Extreme_Weight-vs-Obese |
9.449200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.474000E-01 |
| Obese-vs-Extreme_Obese |
9.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.75809999997312E-06 |
| Normal-vs-Age(41-60Yrs) |
2.52130000000239E-06 |
| Normal-vs-Age(61-80Yrs) |
5.74030001310177E-09 |
| Normal-vs-Age(81-100Yrs) |
2.15289999999646E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.868210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.282200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.188600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.452760E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.506360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.695600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.93789999994409E-07 |
| Normal-VS-Type2 PRCC |
4.11849998549485E-10 |
| Normal-VS-KIRP CIMP |
2.67889999960857E-07 |
| Normal-VS-Unclassified PRCC |
4.157600E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.676200E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.923200E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.600000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.882200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.074300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.208400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.70389999782006E-08 |
| Normal-vs-N1 |
1.14380000004743E-06 |
| Normal-vs-N2 |
1.198890E-04 |
| N0-vs-N1 |
9.458600E-01 |
| N0-vs-N2 |
3.786600E-01 |
| N1-vs-N2 |
3.503400E-01 |
|
|
